These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29227185)

  • 41. Aqueous humor penetration of ketorolac formulated in DuraSite or DuraSite 2 delivery systems compared to Acular LS in rabbits.
    Shafiee A; Bowman LM; Hou E; Hosseini K
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):812-6. PubMed ID: 23992042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual drug delivery from intraocular lens material for prophylaxis of endophthalmitis in cataract surgery.
    Topete A; Serro AP; Saramago B
    Int J Pharm; 2019 Mar; 558():43-52. PubMed ID: 30630077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and pharmacokinetics of intravitreal non-steroidal anti-inflammatory drugs for intraocular inflammation.
    Barañano DE; Kim SJ; Edelhauser HF; Durairaj C; Kompella UB; Handa JT
    Br J Ophthalmol; 2009 Oct; 93(10):1387-90. PubMed ID: 19628498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
    Lu J; English R; Nadelstein B; Weigt A; Berdoulay A; Binder D; Ngan E
    Vet Ophthalmol; 2017 Mar; 20(2):107-113. PubMed ID: 26990912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concentration and dosing of ketorolac versus bromfenac.
    Gayton J
    J Cataract Refract Surg; 2009 Jul; 35(7):1319; author reply 1320. PubMed ID: 19545832
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP; Solomon KD; Sandoval HP; Vroman DT
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV; Westfield KC; Chalkley TH
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of preoperative eyedrops on cytokine concentrations in aqueous humor of patients undergoing femtosecond laser-assisted cataract surgery.
    Lee JH; Chung HS; Moon SY; Yoon J; Lee K; Lee H; Kim JY; Lim HT; Tchah H
    Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):885-891. PubMed ID: 34625847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
    Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
    Retina; 1998; 18(6):521-5. PubMed ID: 9869460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. One-Day Use of Preoperative Topical Nonsteroidal Anti-Inflammatory Drug Prevents Intraoperative Prostaglandin Level Elevation During Femtosecond Laser-Assisted Cataract Surgery.
    Kiss HJ; Takacs AI; Kranitz K; Sandor GL; Toth G; Gilanyi B; Nagy ZZ
    Curr Eye Res; 2016 Aug; 41(8):1064-1067. PubMed ID: 26681407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery.
    Yu-Speight AW; Kern TJ; Erb HN
    Vet Ophthalmol; 2005; 8(3):181-7. PubMed ID: 15910371
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials.
    Zhao X; Xia S; Wang E; Chen Y
    PLoS One; 2017; 12(3):e0173254. PubMed ID: 28253334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
    Heier JS; Topping TM; Baumann W; Dirks MS; Chern S
    Ophthalmology; 2000 Nov; 107(11):2034-8;discussion 2039. PubMed ID: 11054327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.
    Waterbury LD; Galindo D; Villanueva L; Nguyen C; Patel M; Borbridge L; Attar M; Schiffman RM; Hollander DA
    J Ocul Pharmacol Ther; 2011 Apr; 27(2):173-8. PubMed ID: 21351868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis.
    Duan P; Liu Y; Li J
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):639-649. PubMed ID: 28130595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The quantitative effect of 0.5% ketorolac tromethamine solution and 0.1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier.
    Flach AJ; Kraff MC; Sanders DR; Tanenbaum L
    Arch Ophthalmol; 1988 Apr; 106(4):480-3. PubMed ID: 3355415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
    Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
    Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on clinical pathophysiology of pseudophakic/aphakic eyes--a journey of 4 decades].
    Miyake K
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):214-45; discussion 246. PubMed ID: 18411712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.